NCT01705730View on ClinicalTrials.gov

A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 12, 2014

Study Completion Date

December 12, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

tocilizumab

Participants received tocilizumab monotherapy according to individualized physician-prescribed regimens.

Trial Locations (17)

1020

CHU Brugmann (Victor Horta), Brussels

1070

Hospital Erasme; Neurologie, Brussels

1340

Clinique St Pierre asbl, Ottignies

2300

AZ Turnhout Sint Jozef, Turnhout

2610

Sint Augustinus Wilrijk, Wilrijk

3600

Reumaclinic, Genk

4000

Chr de La Citadelle, Liège

Clinique Saint-Joseph, Liège

6000

GHdC Site Saint-Joseph, Gilly (Charleroi)

6041

Clinique Notre Dame de Grâce, Gosselies

7000

CHU Ambroise Paré, Mons

7100

CH Jolimont - Lobbes (Jolimont), Haine-Saint-Paul

7800

CH EpiCURA Site Ath, Ath

8400

AZ Damiaan, Ostend

8500

AZ Groeninge, Kortrijk

8800

AZ Delta (Campus Wilgenstraat), Roeselare

9300

ASZ Aalst, Aalst

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01705730 - A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy | Biotech Hunter | Biotech Hunter